Stay updated on Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The latest version shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates a platform update rather than changes to study content.
    Difference
    0.0%
    Check dated 2026-07-03T23:52:10.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page history now records a new revision (v3.6.2) and removes an older revision (v3.6.0), updating the version history to reflect the latest state of the page.
    Difference
    0.0%
    Check dated 2026-06-27T00:20:45.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    New navigation items 'Check who can join' and 'Find Contact Information' appear on the study record history. The revision label updates to Revision: v3.6.0, replacing the previous v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-12T16:45:50.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page history shows Revision: v3.5.5 replacing the previous v3.5.4, indicating a small update to the record's metadata.
    Difference
    0.0%
    Check dated 2026-06-05T11:47:44.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A new page revision label v3.5.4 was added to the history, replacing the previous v3.5.3. This indicates an update to the study record's revision history.
    Difference
    0.0%
    Check dated 2026-05-15T05:57:25.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Updates to the study record history view showing a newer submitted version (2026-04-21) and that the prior version number/revision (v3.5.2) was removed, with the change list referencing categories like Contacts/Locations and Study Status.
    Difference
    0.2%
    Check dated 2026-04-24T05:54:25.000Z thumbnail image

Stay in the know with updates to Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page.